UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Daxx cooperates with the axin/HIPK2/p53 complex to induce cell death

Cancer research (Chicago, Ill.), 2007, Vol.67 (1), p.66-74

2007

Volltextzugriff (PDF)

Abstract 783: miR-375 downregulates VEGFA via YAP1-EBRR2 pathway in esophageal cancer

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.783-783

2019

Volltextzugriff (PDF)

Abstract 506: miR-203a-3p may play a tumor suppressor role in esophageal cancer by targeting GATA Binding Protein 6

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.506-506

2018

Volltextzugriff (PDF)

Abstract 498: Dual functions of miR-200b in triple-negative breast cancer metastasis and chemoimmuno-resistance

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.498-498

2018

Volltextzugriff (PDF)

Abstract 1072: miR-671-5p and miR-638 serve as novel biomarkers for early breast cancer detection

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.1072-1072

2016

Volltextzugriff (PDF)

Genome-Wide RNAi Screen Identifies PMPCB as a Therapeutic Vulnerability in EpCAM + Hepatocellular Carcinoma

Cancer research (Chicago, Ill.), 2019-05, Vol.79 (9), p.2379-2391

2019

Volltextzugriff (PDF)

Abstract 5549: First-in-class TNFR2 agonist & antagonist antibodies as Treg-Teff modulator for cancer immunotherapy

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.5549-5549

2022

Volltextzugriff (PDF)

Abstract 5307: Preclinical evaluation of a potential FIC 4-1BB/CD24 bispecific antibody IBD0333

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.5307-5307

2024

Volltextzugriff (PDF)

Abstract 4080: IBB0979, A novel B7H3/IL-10 immunocytokine of monovalent anti-B7H3 antibody fused with IL-10 homodimer

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.4080-4080

2024

Volltextzugriff (PDF)

Abstract 1324: Genomic and clinical characteristics of MET exon14 alterations in 26,391 Chinese cancer patients

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.1324-1324

2020

Volltextzugriff (PDF)

Abstract 549: Genome-wide CRISPR-Cas9 screen and RNAseq analysis identify new candidate synthetic lethality partners to PARP inhibitor in triple-negative breast cancer

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.549-549

2020

Volltextzugriff (PDF)

Abstract 4597: 5-Hydroxymethylcytosine signatures in cell-free DNA as a potential biomarker for colorectal cancer andprecancerous adenoma

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.4597-4597

2020

Volltextzugriff (PDF)

Abstract 1888: IAE0972, A novel EGFR/IL10 immunocytokine of monovalent anti-EGFR antibody fused with IL10 homodimer

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.1888-1888

2023

Volltextzugriff (PDF)

Abstract 1889: IAP0971, A novel PD1/IL15 immunocytokine that binds specifically to PD1 and fuses IL15/IL15Rα complex

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.1889-1889

2023

Volltextzugriff (PDF)

Abstract 730: Validation of a NGS-based MSI testing workflow in liquid biopsy

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.730-730

2020

Volltextzugriff (PDF)

Abstract 741: Molecular and clinicopathological characteristics of Chinese non-small cell lung cancers with ROS1 gene fusions identified by next-generation sequencing

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.741-741

2020

Volltextzugriff (PDF)

Mutant U2AF1-Induced Mis-Splicing of mRNA Translation Genes Confers Resistance to Chemotherapy in Acute Myeloid Leukemia

Cancer research (Chicago, Ill.), 2024-05, Vol.84 (10), p.1583-1596

2024

Volltextzugriff (PDF)

Abstract CT170: D-0316 in patients with advanced T790M-positive EGFR-mutant non-small cell lung cancer who progressed on prior EGFR-TKI therapy: results from a phase II study (NCT03861156)

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.CT170-CT170

2021

Volltextzugriff (PDF)

Abstract CT518: First-in-human dose-escalation study of the phosphatidylinositol 3-kinase α-selective inhibitor HS-10352 in advanced breast cancer

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.CT518-CT518

2022

Volltextzugriff (PDF)

Abstract PS8-29: Rare variants in the germline genome holistically determine receptor-independent Her2 signaling pathway activation and immune suppression, shaping pathological type and risk of HER2-negative breast cancer

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS8-29-PS8-29

2021

Volltextzugriff (PDF)

Abstract 2311: Analysis of glypican 3-targeted chimeric antigen receptor T cells in hepatocellular carcinoma cell and mouse models

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.2311-2311

2019

Volltextzugriff (PDF)

Abstract PS12-23: Development of H3B-6545, a first-in-class oral selective ER covalent antagonist (SERCA), for the treatment of ERaWT and ERaMUT breast cancer

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS12-23-PS12-23

2021

Volltextzugriff (PDF)

Abstract P4-01-43: PyrotInib in combination with Capecitabine for trasTUzumab-REsistant, HER2-positive advanced breast cancer (PICTURE): a multicenter phase 2 trial

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.P4-P4-01-43

2023

Volltextzugriff (PDF)

Abstract CT235: RNA-seq molecular subtypes and gene expression signatures in the phase 3 IMpower151 study of 1L bevacizumab + pemetrexed/paclitaxel ± atezolizumab in metastatic NSCLC

Cancer research (Chicago, Ill.), 2024-04, Vol.84 (7_Supplement), p.CT235-CT235

2024

Volltextzugriff (PDF)

Abstract 126: A chemogenomic approach reveals the action of splicing modulators at the branch point adenosine binding pocket defined by the PHF5A/SF3b complex

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.126-126

2017

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieCancer Research

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)
Japanisch
(1)

Erscheinungsjahr

n.n

Kollektion

Menü

Weitere Dienste

Einstellungen

Daxx cooperates with the axin/HIPK2/p53 complex to induce cell death

Abstract 783: miR-375 downregulates VEGFA via YAP1-EBRR2 pathway in esophageal cancer

Abstract 506: miR-203a-3p may play a tumor suppressor role in esophageal cancer by targeting GATA Binding Protein 6

Abstract 498: Dual functions of miR-200b in triple-negative breast cancer metastasis and chemoimmuno-resistance

Abstract 1072: miR-671-5p and miR-638 serve as novel biomarkers for early breast cancer detection

Genome-Wide RNAi Screen Identifies PMPCB as a Therapeutic Vulnerability in EpCAM + Hepatocellular Carcinoma

Abstract 5549: First-in-class TNFR2 agonist & antagonist antibodies as Treg-Teff modulator for cancer immunotherapy

Abstract 5307: Preclinical evaluation of a potential FIC 4-1BB/CD24 bispecific antibody IBD0333

Abstract 4080: IBB0979, A novel B7H3/IL-10 immunocytokine of monovalent anti-B7H3 antibody fused with IL-10 homodimer

Abstract 1324: Genomic and clinical characteristics of MET exon14 alterations in 26,391 Chinese cancer patients

Abstract 549: Genome-wide CRISPR-Cas9 screen and RNAseq analysis identify new candidate synthetic lethality partners to PARP inhibitor in triple-negative breast cancer

Abstract 4597: 5-Hydroxymethylcytosine signatures in cell-free DNA as a potential biomarker for colorectal cancer andprecancerous adenoma

Abstract 1888: IAE0972, A novel EGFR/IL10 immunocytokine of monovalent anti-EGFR antibody fused with IL10 homodimer

Abstract 1889: IAP0971, A novel PD1/IL15 immunocytokine that binds specifically to PD1 and fuses IL15/IL15Rα complex

Abstract 730: Validation of a NGS-based MSI testing workflow in liquid biopsy

Abstract 741: Molecular and clinicopathological characteristics of Chinese non-small cell lung cancers with ROS1 gene fusions identified by next-generation sequencing

Mutant U2AF1-Induced Mis-Splicing of mRNA Translation Genes Confers Resistance to Chemotherapy in Acute Myeloid Leukemia

Abstract CT170: D-0316 in patients with advanced T790M-positive EGFR-mutant non-small cell lung cancer who progressed on prior EGFR-TKI therapy: results from a phase II study (NCT03861156)

Abstract CT518: First-in-human dose-escalation study of the phosphatidylinositol 3-kinase α-selective inhibitor HS-10352 in advanced breast cancer

Abstract PS8-29: Rare variants in the germline genome holistically determine receptor-independent Her2 signaling pathway activation and immune suppression, shaping pathological type and risk of HER2-negative breast cancer

Abstract 2311: Analysis of glypican 3-targeted chimeric antigen receptor T cells in hepatocellular carcinoma cell and mouse models

Abstract PS12-23: Development of H3B-6545, a first-in-class oral selective ER covalent antagonist (SERCA), for the treatment of ERaWT and ERaMUT breast cancer

Abstract P4-01-43: PyrotInib in combination with Capecitabine for trasTUzumab-REsistant, HER2-positive advanced breast cancer (PICTURE): a multicenter phase 2 trial

Abstract CT235: RNA-seq molecular subtypes and gene expression signatures in the phase 3 IMpower151 study of 1L bevacizumab + pemetrexed/paclitaxel ± atezolizumab in metastatic NSCLC

Abstract 126: A chemogenomic approach reveals the action of splicing modulators at the branch point adenosine binding pocket defined by the PHF5A/SF3b complex

Aktive Filter

Suchergebnisse filtern